Title:
XBP1 PEPTIDES, CD138 PEPTIDES, AND CS1 PEPTIDES
Document Type and Number:
Japanese Patent JP2023134812
Kind Code:
A
Abstract:
To provide XBP1 peptides, CD138 peptides, and CS1 peptides.SOLUTION: The disclosure features, inter alia, immunogenic XBP1-, CD138-, and CS1-derived peptides (and pharmaceutical compositions thereof). The peptides can be used in a variety of methods such as methods for inducing an immune response, methods for producing an antibody, and methods for treating a cancer (e.g., a plasma cell disorder such as multiple myeloma or Waldenstrom's macroglobulinemia). The peptides can also be included in MHC molecule multimer compositions and used in, e.g., methods for detecting a T cell in a population of cells.SELECTED DRAWING: None
Inventors:
NIKHIL C MUNSHI
BAE JOOEUN
ANDERSON KENNETH C
BAE JOOEUN
ANDERSON KENNETH C
Application Number:
JP2023120931A
Publication Date:
September 27, 2023
Filing Date:
July 25, 2023
Export Citation:
Assignee:
DANA FARBER CANCER INST INC
International Classes:
C12N15/12; A61K9/19; A61K35/15; A61K35/17; A61K38/08; A61K39/00; A61K39/39; A61K45/00; A61K48/00; A61P35/00; A61P37/04; A61P43/00
Attorney, Agent or Firm:
Shusaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto